Navigation Links
Colonoscopy screening every ten years could prevent 40% of colorectal cancers

Boston, MA -- According to a large, long-term study from Harvard School of Public Health (HSPH), 40% of all colorectal cancers might be prevented if people underwent regular colonoscopy screening. The new research also supports existing guidelines that recommend that people with an average risk of colorectal cancer should have a colonoscopy every 10 years.

The new study helps address previous uncertainty about the effectiveness of colonoscopy in reducing colorectal cancer incidence and mortality -- particularly among people with cancer that originates in the proximal, or upper part of the colon.

The study appears in the September 19, 2013 edition of the New England Journal of Medicine.

"Colonoscopy is the most commonly used screening test in the U.S. but there was insufficient evidence on how much it reduces the risk of proximal colon cancer and how often people should undergo the procedure," said Shuji Ogino, co-senior author and associate professor in the Department of Epidemiology at HSPH. "Our study provides strong evidence that colonoscopy is an effective technique for preventing cancers of both distal and proximal regions of the colorectum, while sigmoidoscopy alone is insufficient for preventing proximal cancer."

According to the most recent statistics from the Centers for Disease Control and Prevention, nearly 137,000 people in the U.S. were diagnosed with colorectal cancer in 2009, and nearly 52,000 died that year from the disease. Colorectal cancer is the second-leading cause of cancer-related death in the nation.

The researchers analyzed data from 88,902 participants in two long-term studies: the Nurses' Health Study and the Health Professionals Follow-up Study. Based on data from questionnaires that participants filled out every two years between 1988 and 2008, the researchers obtained information on colonoscopy and sigmoidoscopy procedures. They documented 1,815 cases of colorectal cancer and 474 deaths from the disease.

They found that both colonoscopy and sigmoidoscopy -- which screens for tumors in the distal, or lower part of the colorectum -- were associated with decreased risk of either getting colorectal cancer or dying from it. Only colonoscopy decreased the risk for cancers originating in the proximal colon, but not to the degree of its protective effect against distal colorectal cancers. The researchers suggested that colonoscopy's smaller effect in reducing risk for tumors in the proximal colon might be due in part to molecular or biological differences in those cancers.

Other findings include:

  • The researchers estimated that if all participants in the study had undergone colonoscopies, 40% of colorectal cancers -- including 61% of distal cancers and 22% of proximal cancers -- would have been prevented.

  • Sigmoidoscopy alone is likely insufficient for reducing the incidence or death risk of colorectal cancer that originates in the upper colon.

  • People who get a clean bill of health after a colonoscopy have a significantly reduced risk of colorectal cancer for up to 15 years after the procedure, although the data support repeat screening at shorter intervals among individuals with a personal history of adenoma -- a benign tumor of glandular origin that can become malignant over time -- or a family history of colorectal cancer.

  • Colorectal cancers diagnosed within five years of a colonoscopy had different molecular characteristics compared with cancers diagnosed more than five years after a colonoscopy, and they may be difficult to detect or completely remove.

"Each year, more than 1.2 million people are diagnosed with colorectal cancer worldwide. Our findings could help improve and strengthen the current guidelines for colorectal cancer screening," said Reiko Nishihara, lead author and research fellow in the Department of Nutrition at HSPH.

Support for the study came from the National Institutes of Health (P01 CA87969, P01 CA55075, 1UM1 CA167552, P50 CA127003, R01 CA151993, R01 CA137178, and K24 DK098311); the Bennett Family Foundation; and the Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance.

"Long-term colorectal-cancer incidence and mortality after lower endoscopy," Reiko Nishihara, Kana Wu, Paul Lochhead, Teppei Morikawa, Xiaoyun Liao, Zhi Rong Qian, Kentaro Inamura, Sun A. Kim, Aya Kuchiba, Mai Yamauchi, Yu Imamura, Walter C. Willett, Bernard A. Rosner, Charles S. Fuchs, Edward Giovannucci, Shuji Ogino, Andrew T. Chan, New England Journal of Medicine, September 19, 2013, 369:1095-1105

Visit the HSPH website for the latest news, press releases and multimedia offerings.


Contact: Marge Dwyer
Harvard School of Public Health

Related biology technology :

1. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
2. SpermCheck® Fertility, the Only FDA Approved At-Home Screening Test for Men to Determine Normal or Low Sperm Count, Now Available to Couples Planning or Struggling to Conceive
3. Luminex Corporation Receives CE Mark for Revolutionary Newborn Screening Platform
4. Trovagene and Strand Life Sciences Plan Collaboration to Validate and Offer Urine-Based HPV Screening Test in India and South Asia
5. BioRealm to Develop Universal Genetic Screening Tool for Tobacco Addiction and Treatment
6. Dallas-Fort Worth Fertility Associates Celebrates First Birth in North Texas from Advanced Trophectoderm Biopsy Screening Technology
7. Genedata Screener for HCS Advances Phenotypic Screening
8. IntelliCyt Introduces New System for Multiplexed Screening of Suspension Assays
9. Genedata Screener Adopted for all Plate-based Screening by Major Pharmas
10. Charm Sciences EZ System Accepted for Antibiotic Testing of Raw Milk in the US NCIMS Residue Screening Program
11. Seeing the Future: How a Revolutionary New Bacterial Screening Device can Predict a Patient’s Future for Tooth Decay
Post Your Comments:
(Date:10/8/2015)... ... 2015 , ... Cystic fibrosis (CF) is a genetic disease ... results in dysfunction of the lungs and the gastrointestinal (GI) tract. In CF ... very difficult to clear, blocks the airways and the glands, and creates an ...
(Date:10/7/2015)... ... , ... Neil Riordan, PhD to Discuss Medicinal Effects of Mesenchymal Stem Cells ... 3:50 pm to 4:30 pm. , Dr. Riordan is one of the early pioneers ... the Co-Founder and Chief Science Officer of the Riordan-McKenna Institute of Regenerative ...
(Date:10/7/2015)... Oct. 7, 2015  ContraVir Pharmaceuticals, Inc. (Nasdaq: ... focused on the development and commercialization of targeted antiviral ... offering of 5,000,000 shares of its common stock and ... Company,s common stock at a fixed combined price to ... and warrants will be issued separately.  The warrants will ...
(Date:10/7/2015)... Oct. 7, 2015   VWR (NASDAQ: ... laboratory products, services and solutions, announced today that ... specialty solvent company that performs high volume purification ... enhance VWR,s growing laboratory and production chemical manufacturing ... manufacturing customers. Manuel Brocke-Benz , President ...
Breaking Biology Technology:
... drive to make healthcare information technology interoperable across ... and a medical information technology company headquartered here ... is lending its expertise to developing an ... the healthcare industry. Specifically, the expertise of Damien ...
... Sonic Foundry, Inc. has announced that it ... the fourth quarter of 2006, its first cash-positive quarter ... been building toward profitability since moving into the rich-media ... which the company showcased new search technology. , ,The ...
... . - Following weeks of blistering criticism of its electronic ... Foundation Health Plan , Madison's Epic Systems Corp . ... defending its product. , ,Epic Systems, a medical software developer, ... its electronic records system, which Kaiser has re-branded with the ...
Cached Biology Technology:
(Date:9/30/2015)... , Sept. 30, 2015  The global glucose monitoring ... for 2015. So says a new report on the industry ... management segment dominate the market, followed by continuous glucose monitoring ... reports on the market for these products in its latest ... ...
(Date:9/28/2015)... 2015  The monitoring of vital signs, such ... is an essential component of patient assessment. Changes ... in a patient,s condition. However, in general care ... taken during routine observation rounds only once every ... between these observation rounds, the warning signs can ...
(Date:9/26/2015)... 2015  Results of a TactioRPM pilot project ... at the Stanford Medicine X Conference. In a ... Connected Health Devices and Pharmacogenomics", Roger Simard ... explain how senior patients equipped with connected health ... via the TactioRPM remote patient monitoring platform were ...
Breaking Biology News(10 mins):
... in traffic may cause a headache, but a delay ... of Missouri researchers have uncovered clues identifying which proteins ... and found that the proteins previously thought to play ... the nervous system develops will give researchers a better ...
... A team of Vanderbilt University Medical Center investigators has ... a new class of drugs for treating cancer., The ... phospholipase D (PLD), an enzyme that has been implicated ... colorectal., The new inhibitors, reported in the February issue ...
... gardening can offer enough moderate physical activity to keep older ... February in the journal HortScience , the researchers discovered ... older hands strong and nimble. "One of the things ... better hand strength and pinch force, which is a big ...
Cached Biology News:
Mouse monoclonal [3G8] to MDMA ( Abpromise for all tested applications)....
Ly-49C and Ly-49I Biotin Anti-Mouse clone 5E6, Isotype Mouse IgG 2a , kappa, 0.1 mg Consult technical datasheet for details....
Fluorescein isothiocyanate (FITC) mouse anti-human IFN-alpha2 25 tests...
Dog polyclonal to Porcine Pancreatic Islets of Langerhans Cells ( Abpromise for all tested applications). Antigen: Tissue / cell preparation (Pig): Sonicated crude membrane fraction of porcine p...
Biology Products: